Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/27/2004 | EP1470146A2 Antibodies against the muc18 antigen |
10/27/2004 | EP1469877A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
10/27/2004 | EP1469741A1 A process for the extraction,purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent |
10/27/2004 | EP1469738A1 Cheese flavour ingredient and method of its production |
10/27/2004 | EP0871885B1 Attachment enhanced 293 cells |
10/27/2004 | EP0845270B1 Functional fragment antigen of tetanus toxin and tetanus vaccine |
10/27/2004 | EP0807125B1 Monoclonal antibodies anti-cd6 for the treatment and diagnosis of psoriasis |
10/27/2004 | EP0763107B1 Pantropic neurotrophic factors |
10/27/2004 | EP0721015B1 Monoclonal antibody that induces apoptosis |
10/27/2004 | EP0717108B1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
10/27/2004 | CN1541275A Glycoprotein and process for producing same |
10/27/2004 | CN1541271A Methods for large scale prodn. of recombinant DNA-derived tPA or K2S molecules |
10/27/2004 | CN1541269A Human protooncogene KG-zo and protein encoded therein |
10/27/2004 | CN1541266A FCE fusion proteins for treatment of allergy and asthma |
10/27/2004 | CN1541226A Antibodes specific for CD44V6 |
10/27/2004 | CN1541225A Humanized antibodies that recognize beta amyloid peptide |
10/27/2004 | CN1541224A Antagonistic anti-hTNFSF13b Human antibodies |
10/27/2004 | CN1541111A Mutant forms of cholera holotoxin as adjuvant |
10/27/2004 | CN1541109A Inhibitors of HER3 activity |
10/27/2004 | CN1541059A Plant cell having animal-type sugar chain adding function |
10/27/2004 | CN1539990A Method for producing fermented nucleotide typed antibiotics by using membrane |
10/27/2004 | CN1539989A Method for producing antigen protein in use for hog cholera vaccine |
10/27/2004 | CN1539978A Expression vector, engineering bacteria of N* deacetylating Alpha 1 monomer of human thymosin, and preparation method |
10/27/2004 | CN1539972A cDNA segment of controlling growth of microspore of paddy, coded result and application |
10/27/2004 | CN1539970A Heterophil neutral leucocyte factor alpha |
10/27/2004 | CN1539849A Polypeptides encoded by haman lipase-like gene and compsns, and metods of utilizing same |
10/27/2004 | CN1173038C Recombinant human dyad stem cell factor and preparing thereof |
10/27/2004 | CN1173037C Single-chain bifunctional glycoprotein hormones |
10/27/2004 | CN1173033C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
10/27/2004 | CN1172954C High-expression gene of liver cancer, proteni coded by it and its application |
10/27/2004 | CN1172952C Mannosan peptide and its prepn and use |
10/26/2004 | US6809239 Choline monooxygenase gene |
10/26/2004 | US6809178 Polypeptide for use in the treatment of addison's disease |
10/26/2004 | US6809078 Nucleotide sequences coding polypeptide use in the generation of insect resistant plants; biological pest control |
10/26/2004 | US6808914 Nucleotide sequences coding polypeptide for use in the biosynthesis of amino acid for use in human medicine and animal nutrients |
10/26/2004 | US6808913 Comprises genetically engineered subtilisin for improved washing abilty of deteregents |
10/26/2004 | US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
10/26/2004 | US6808898 Low oxygen affinity mutant hemoglobins |
10/26/2004 | US6808882 Isolating preferential nucleotide sequences; obtain nucleotide sequence samples, encapsulate into microcapsules, monitor gene expression activities |
10/26/2004 | CA2263888C Methods and compositions for the detection of cervical cancer |
10/26/2004 | CA2261999C Invertase inhibitor |
10/26/2004 | CA2177616C Preparation and use of immunoconjugates |
10/26/2004 | CA1341461C T helper cell growth factor |
10/21/2004 | WO2004090155A2 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
10/21/2004 | WO2004090151A2 Method for extracting collagen comprising microbial fermentation |
10/21/2004 | WO2004090117A1 Yeast host, tranfsormant and process for producing foreign protein |
10/21/2004 | WO2004090115A2 Renilla gfp mutants with increased fluorescent intensity and special shift |
10/21/2004 | WO2004089305A2 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same |
10/21/2004 | WO2004089097A1 Composition with heart rate reducing properties |
10/21/2004 | WO2004043989A3 Human monoclonal antibodies to heparanase |
10/21/2004 | WO2004035764A3 PROTEIN SYNTHESIS WITH TANDEMLY ACTIVATED tRNAs |
10/21/2004 | WO2004032832A3 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
10/21/2004 | WO2004019000A3 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
10/21/2004 | WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
10/21/2004 | WO2003024392A3 Compositions and methods for the diagnosis and treatment of tumor |
10/21/2004 | WO2003000014A3 Spherical protein particles and methods of making and using them |
10/21/2004 | US20040210953 Lysozyme transgenic ungulates |
10/21/2004 | US20040210950 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS) |
10/21/2004 | US20040210039 Keratin-based products and methods for their productions |
10/21/2004 | US20040210038 Il-1 eta DNA and polypeptides |
10/21/2004 | US20040210037 Comprises major histocompatibility complex fusion protein for use in treating and/or preventing cancer, infection, allergies and autoimmune diseases |
10/21/2004 | US20040209797 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
10/21/2004 | US20040209333 administering subtilisins obtained from grampositive bacterial residues that vitamin k2 has been removed using chitosan |
10/21/2004 | US20040209326 Immunoglobulin for use in detection and prevention staphylococcus infections |
10/21/2004 | US20040209324 Comprises genetically altered thrombopoietin for use in treatment of thrombocytopenia; gene therapy and therapeutic proteins |
10/21/2004 | US20040209323 Protein expression by codon harmonization and translational attenuation |
10/21/2004 | US20040209321 Methods of in vitro protein synthesis |
10/21/2004 | US20040209318 Reagents and methods for the detection and quantification of vancomycin in bilogical fluids |
10/21/2004 | US20040209306 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
10/21/2004 | US20040209277 Transcription factor comprising zinc finger domain for use in controlling neuronal and osteoblast differentiation |
10/21/2004 | US20040209264 Comprises nucleotide sequences coding daugther of legless protein for use in identifying modulator for tissue regeneration and repair and the treatment of blood disorders |
10/21/2004 | US20040209248 Comprises modified viral surface protein for use in detection and diagnosis of hepatitis infection |
10/21/2004 | US20040208883 Method for preparing ester linked peptide-carbohydrate conjugates |
10/21/2004 | US20040208881 B1k chain of laminin and methods of use |
10/21/2004 | US20040208878 Treatment of acute lung injury, fibrosis and metastasis with antagonists of alphabetav6 |
10/21/2004 | CA2521631A1 Composition with heart rate reducing properties |
10/21/2004 | CA2521402A1 Pectate lyases, nucleic acids encoding them and methods for making and using them |
10/21/2004 | CA2521273A1 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
10/20/2004 | EP1469316A1 Screening method |
10/20/2004 | EP1469310A1 Diagnostic for scleroderma |
10/20/2004 | EP1469074A1 Human calcium channel compositions and methods |
10/20/2004 | EP1468695A1 Methods and compositions useful for inhibition of angiogenesis |
10/20/2004 | EP1468106A2 Optimization of temperature shifting in high cell-density fermentations |
10/20/2004 | EP1468105A2 Recombinant protein expression |
10/20/2004 | EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS |
10/20/2004 | EP1468079A1 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
10/20/2004 | EP1468019A2 Secreted protein |
10/20/2004 | EP1468018A2 Leptin proteins |
10/20/2004 | EP1468012A1 Biomolecule transduction motif mph-1-btm and the use thereof |
10/20/2004 | EP1468011A1 Biomolecule transduction motif sim-2-btm and the use thereof |
10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
10/20/2004 | EP1467615A1 Methods to engineer mammalian-type carbohydrate structures |
10/20/2004 | EP1194450B1 Inactivated vaccine against feline calicivirus disease |
10/20/2004 | EP1104772B1 Anti-l7/l12 antibody for detecting bacteria |
10/20/2004 | EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
10/20/2004 | EP0935604A4 Magnetically activated cell sorting for production of proteins |
10/20/2004 | EP0904107B1 Immunoglobin-like domains with increased half lives |
10/20/2004 | EP0886644B1 Long wavelength engineered fluorescent proteins |
10/20/2004 | EP0859050B1 Alkaline protease, process for the production thereof, use thereof, and microorganism producing the same |